the eastern cooperative oncology group ( ecog ) trial of adjuvant cyclophosphamide , methotrexate , fluorouracil , and prednisone ( cmfp ) or cmfp plus tamoxifen ( cmfpt ) for 1 year compared with observation alone in 265 postmenopausal patients with node-positive breast cancer is reported with 74 months median follow-up .
C0025677
cmfp
C0055986
cmfpt